Mankind Pharma
Series A
Investment thesis
BSV develops and commercializes innovative biopharmaceutical therapies targeting complex healthcare challenges across India and emerging markets. The company builds its strategy on groundbreaking research, strong IP capabilities, and a niche product pipeline, supported by state-of-the-art R&D centers staffed with over 60 scientists.
Source: firm website, verified Jul 21, 2026.
Frequently asked questions
- What stage does Mankind Pharma invest at?
- Mankind Pharma invests at the Series A stage.
- What sectors does Mankind Pharma focus on?
- Mankind Pharma focuses on Biotech.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
Blume Ventures is a seed and pre-Series A investment firm headquartered in Mumbai that focuses on early-stage companies in India.